Boothbay Fund Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-30,362
| Closed | -$2.64M | – | 1873 |
|
|
2021
Q3 | $2.64M | Sell |
30,362
-13,560
| -31% | -$1.18M | 0.07% | 267 |
|
|
2021
Q2 | $3.6M | Buy |
43,922
+27,892
| +174% | +$2.28M | 0.12% | 163 |
|
|
2021
Q1 | $1.53M | Buy |
+16,030
| New | +$1.53M | 0.06% | 337 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 922 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 869 |
|
|
2019
Q2 | – | Sell |
-12,409
| Closed | -$973K | – | 720 |
|
|
2019
Q1 | $973K | Buy |
+12,409
| New | +$973K | 0.09% | 176 |
|